Search

Filter by
  • Page 1 of 4 // 39 Results found
    • Sort by:

Data

Evidence of the immunogenicity of the HPV vaccine in HIV-infected men and women

Table -

Efficacy, immunogenicity, safety and tolerability in other populations not previously targeted by immunisation programmes: HIV-infected

Data

Evidence of the immunogenicity of the 9vHPV vaccine

Table -

Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine

Publication

Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction

Technical guidance -

This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.

Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction - EN - [PDF-1.61 MB]

Peer-Reviewed Publication

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

Jan 2019 - Hum Vaccin Immunother - 15(7-8):1615-1627

Karafillakis, E., Simas, C., Jarrett, C., Verger, P., Peretti-Watel, P., Dib, F., De Angelis, S., Takacs, J., Ali, K.A., Pastore Celentano, L., Larson, H.